Insight Molecular Diagnostics Inc.

IMDX · XNAS

CIK 1642380fmd_1VZEPPC1HQZTPN4VS4TR5DX5NGManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2014 to Jun 30, 2026, 47 periods

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).